Clinical Trial Update: Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating recombinant human thrombopoietin as supportive care for children receiving ifosfamide, carboplatin, and etoposide chemotherapy, acros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors
• Hepatic Cancer
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Germ Cell Tumors, Hepatic Cancer | Phase 1, Phase 2 | Status: COMPLETED